International BioChemical Industries Inc has signed a master distribution agreement with its joint partner Nova BioGenetics Inc. IBCI has entered into this agreement to strengthen its capability for marketing of its products. IBCI will continue to provide R&D technical support to Nova as well as production of products, while maintaining a stronger profit margin due to reduction in overhead.

The company believes this approach will strengthen sales into the market and develop a stronger pipeline. Under this agreement Nova will undertake all sales efforts for IBCI products, technical sales support and marketing programs. Nova has demonstrated they're capable of bringing strong distribution connections to the technology and the ability to move forward on sales agreements.

Nova's financial commitment to marketing IBCI's products will give IBCI the required strength to move the products forward with the appropriate marketing and staff.